NO20001829L - Forsinket total frigivelse av magetarm-avleveringssystem for medikament - Google Patents

Forsinket total frigivelse av magetarm-avleveringssystem for medikament

Info

Publication number
NO20001829L
NO20001829L NO20001829A NO20001829A NO20001829L NO 20001829 L NO20001829 L NO 20001829L NO 20001829 A NO20001829 A NO 20001829A NO 20001829 A NO20001829 A NO 20001829A NO 20001829 L NO20001829 L NO 20001829L
Authority
NO
Norway
Prior art keywords
core
drug
coating
insoluble
delivery system
Prior art date
Application number
NO20001829A
Other languages
English (en)
Other versions
NO20001829D0 (no
Inventor
E Itzhak Lerner
Moshe Flashner
Adel Penhasi
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of NO20001829D0 publication Critical patent/NO20001829D0/no
Publication of NO20001829L publication Critical patent/NO20001829L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20001829A 1997-10-09 2000-04-07 Forsinket total frigivelse av magetarm-avleveringssystem for medikament NO20001829L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94823597A 1997-10-09 1997-10-09
US16320298A 1998-09-30 1998-09-30
PCT/US1998/020779 WO1999018938A1 (en) 1997-10-09 1998-10-01 Delayed total release gastrointestinal drug delivery system

Publications (2)

Publication Number Publication Date
NO20001829D0 NO20001829D0 (no) 2000-04-07
NO20001829L true NO20001829L (no) 2000-06-07

Family

ID=26859435

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001829A NO20001829L (no) 1997-10-09 2000-04-07 Forsinket total frigivelse av magetarm-avleveringssystem for medikament

Country Status (20)

Country Link
EP (1) EP1021171B1 (no)
JP (1) JP2001519379A (no)
KR (1) KR20010031034A (no)
CN (1) CN100548279C (no)
AT (1) ATE238774T1 (no)
AU (1) AU740757B2 (no)
BR (1) BR9815240A (no)
CA (1) CA2305762C (no)
CZ (1) CZ301028B6 (no)
DE (1) DE69814122T2 (no)
DK (1) DK1021171T3 (no)
ES (1) ES2198756T3 (no)
HU (1) HUP0004945A3 (no)
IL (1) IL135502A (no)
NO (1) NO20001829L (no)
NZ (1) NZ503820A (no)
PL (1) PL203733B1 (no)
PT (1) PT1021171E (no)
TR (1) TR200000944T2 (no)
WO (1) WO1999018938A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
CA2378265C (en) 1999-08-09 2007-11-20 Dainippon Pharmaceutical Co., Ltd. Solid preparations containing chitosan powder and process for producing the same
CN1285333C (zh) * 2000-06-07 2006-11-22 张昊 结肠定位释放的口服制剂及其制备方法
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
EP1377276B1 (en) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Timed pulse release composition
TW200303919A (en) * 2001-12-05 2003-09-16 Hiroyuki Ohno Cytotoxic protein and the use
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
KR100592511B1 (ko) * 2002-12-30 2006-07-03 안경섭 벤즈이미다졸 유도체 또는 약리학적으로 허용되는 이의염을 활성물질로 하는 안정성이 강화된 방출제어형 제제및 그 제조방법
CA2523158C (en) 2003-04-24 2010-11-16 Jagotec Ag Delayed release tablet with defined core geometry
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
KR100645019B1 (ko) * 2004-06-03 2006-11-14 주식회사 리젠 바이오텍 비수용성 무기화합물이 포집되어 있는 고분자 비드, 이의제조방법 및 용도
CN101137398B (zh) * 2005-01-05 2012-07-04 得克萨斯大学体系董事会 用于双重显像和放射化疗的缀合物：组合物、生产和应用
EP1909765A1 (en) * 2005-07-22 2008-04-16 Dow Gloval Technologies Inc. Oral drug compliance monitoring using sound detection
JP2009502908A (ja) 2005-07-29 2009-01-29 スティッチング グロニンゲン セントル フォー ドラッグ リサーチ ｐＨ制御パルス送達システム、その調製法及び使用法
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
EP1991196B1 (en) 2006-03-03 2016-10-12 Fmc Corporation Method and apparatus for the preparation of capsules.
JP2007284483A (ja) * 2006-04-13 2007-11-01 Daito Kasei Kogyo Kk 吸湿性顔料およびそれを含有する化粧料
AU2007254215A1 (en) * 2006-05-19 2007-11-29 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of viral infections
PT2049123E (pt) 2006-08-03 2013-03-06 Horizon Pharma Ag Tratamento de doença reumatóide com glucocorticóide de libertação retardada
EP2079448A2 (en) * 2006-10-10 2009-07-22 Dexcel Pharma Technologies Ltd. Improved release of statins in the intestine
WO2009064458A2 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090131386A1 (en) 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
EP2179727B1 (en) 2008-10-27 2013-05-29 Roquette Freres Water insoluble polymer: modified starch derivative-based film coatings for colon targeting
MX353623B (es) * 2011-05-13 2018-01-22 Eb Ip Hybritabs B V Sistema de suministro de farmaco.
ES2900426T3 (es) 2013-12-31 2022-03-16 Rapamycin Holdings Llc Preparaciones orales y uso de nanopartículas de rapamicina
EP3107544B1 (en) 2014-02-21 2020-10-07 Principia Biopharma Inc. Salts and solid form of a btk inhibitor
CA2968049A1 (en) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
CA2970723C (en) 2014-12-18 2023-09-05 Principia Biopharma Inc. Treatment of pemphigus
MA41256B1 (fr) * 2014-12-24 2021-02-26 Principia Biopharma Inc Dosage spécifique de site d'un inhibiteur de btk
TW201718572A (zh) 2015-06-24 2017-06-01 普林斯匹亞生物製藥公司 酪胺酸激酶抑制劑
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
CN105434403A (zh) * 2015-12-30 2016-03-30 成都医学院 一种溴吡斯的明包衣缓释微丸及其制备方法
EP3478273A1 (en) 2016-06-29 2019-05-08 Principia Biopharma Inc. Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
JP6780412B2 (ja) * 2016-09-28 2020-11-04 ライオン株式会社 コーティング組成物ならびにコーティング製剤及びその製造方法
CN112544964B (zh) * 2020-12-28 2024-03-19 苏州大学 一种可服用胶囊及其制备方法与应用
CN115176879B (zh) * 2022-09-09 2022-11-18 山东新和成氨基酸有限公司 一种过瘤胃蛋氨酸的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5229131A (en) * 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
DE19603019C2 (de) * 1996-01-17 1998-10-15 Lancaster Group Gmbh Kosmetisches Hautreinigungsmittel auf Basis natürlicher Wirkstoffe
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
JP2000053316A (ja) * 1998-08-06 2000-02-22 Sony Corp フィルム剥離装置

Also Published As

Publication number Publication date
IL135502A0 (en) 2001-05-20
KR20010031034A (ko) 2001-04-16
HUP0004945A3 (en) 2005-03-29
EP1021171A1 (en) 2000-07-26
IL135502A (en) 2006-07-05
BR9815240A (pt) 2001-10-30
AU740757B2 (en) 2001-11-15
AU9600198A (en) 1999-05-03
ES2198756T3 (es) 2004-02-01
PL203733B1 (pl) 2009-11-30
CZ20001256A3 (cs) 2000-10-11
CN1274280A (zh) 2000-11-22
CZ301028B6 (cs) 2009-10-14
WO1999018938A1 (en) 1999-04-22
PL339861A1 (en) 2001-01-15
DE69814122T2 (de) 2004-03-18
HUP0004945A2 (hu) 2001-08-28
DK1021171T3 (da) 2003-08-25
PT1021171E (pt) 2003-10-31
DE69814122D1 (de) 2003-06-05
ATE238774T1 (de) 2003-05-15
CN100548279C (zh) 2009-10-14
NZ503820A (en) 2004-02-27
TR200000944T2 (tr) 2000-11-21
CA2305762C (en) 2006-09-26
EP1021171B1 (en) 2003-05-02
NO20001829D0 (no) 2000-04-07
JP2001519379A (ja) 2001-10-23
CA2305762A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
NO20001829L (no) Forsinket total frigivelse av magetarm-avleveringssystem for medikament
IL146708A0 (en) Delayed total release two pulse gastrointestinal drug delivery system
MY133883A (en) Gastrointestinal drug delivery system
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
DK0673645T3 (da) Farmaceutisk præparat til afgivelse af lægemidler i colon
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
DE60237372D1 (de) Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
US20220125739A1 (en) Abuse and Misuse Deterrent Transdermal Systems
WO2002078601A8 (en) Drug release from polymer matrices through mechanical stimulation
ES2149250T3 (es) Dispositivo para la administracion de medicamentos con liberacion controlada.
NO995313L (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
GB2338414A (en) Intravesical drug delivery system
IE872110L (en) Oral therapeutic system having systemic action
CA2350838A1 (en) Controlled release system for delivering therapeutic agents into the inner ear
WO2004087011A3 (en) Therapeutic agent delivery device with controlled therapeutic agent release rates
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
WO1998026767A3 (en) Site-specific controlled release dosage formulation for mesalamine
WO2001013898A3 (en) Pharmaceutical formulations with different release times
ATE236616T1 (de) Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten
CA2243863A1 (en) Gastrointestinal drug delivery system
FR2806625B1 (fr) Dispositif matriciel pour l'administration transdermique de rilmenidine et son procede de preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application